Presenting characteristics as predictors of duration of treatment in sarcoidosis.
about
A concise review of pulmonary sarcoidosisGene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis.Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-upTreatment of Sarcoidosis.The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysisPulmonary hypertension associated with sarcoidosis.New molecular targets for the treatment of sarcoidosis.Therapy for sarcoidosis: evidence-based recommendations.Clinical management of pulmonary sarcoidosis.Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach.Sarcoidosis: an update on current pharmacotherapy options and future directions.Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease.Sarcoidosis in America. Analysis Based on Health Care Use.Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain.[Sarcoidosis : Organ involvement, diagnosis, current treatment].Sarcoidosis in children: HRCT findings and correlation with pulmonary function tests.Disease Burden and Variability in Sarcoidosis.The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.Phenotyping sarcoidosis from a pulmonary perspective.Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study
P2860
Q24609077-298D0797-296D-42B3-93E4-793D0BB4704FQ30487702-8401A9C8-3F37-479F-AA66-2C67BCBBAC18Q33565066-6531FF19-7935-4693-9CE4-AADB7AB3E5F1Q34477003-0036EDD8-7B6B-4ED9-8F90-676871C1AE18Q35660312-23625FD0-0AC6-4FC8-8AF7-B43A8A7FAE77Q36130969-8EC51786-E7B1-431C-A82B-881768EECE36Q37494750-16144D76-B9FC-4159-BCAA-FF5EFFB2E378Q37965606-8829F739-977A-43A0-B7F7-7FFDDE96698CQ38766783-69CFC6EE-B13D-41C8-82E2-6A1E8A31C9A9Q38773552-D7168987-9952-4F2E-BA2B-BD6B89BE8CFFQ38798146-5A98327A-37D3-454C-A356-6ACFAFF876E3Q39079920-18D814A5-76AB-444B-8C43-B29C77C55C02Q39504304-0E498455-957D-4B57-9EFB-C1ECA3566C50Q40116548-54717BEF-E24A-4150-BC3B-E3C2C85E5279Q41159112-C34D0D9D-D87B-473A-BAE4-D880C041259EQ45714454-E7044163-3C27-4D34-A41F-60F7EAA59BF5Q46218709-1FE15B1F-169D-446D-A5EC-03807EAB7CDDQ46460401-7A016D59-4398-4B1A-A69F-9108992790AEQ46920626-80870182-CB5B-43DA-9274-3F43EF7D7901Q54974263-B5C5C572-FA06-4AAE-B83D-1C32034B4EA1Q57213603-66AE7FB8-D76A-4EF1-8C62-CB39F386E051
P2860
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@ast
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@en
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@nl
type
label
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@ast
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@en
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@nl
prefLabel
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@ast
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@en
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@nl
P2093
P356
P1476
Presenting characteristics as predictors of duration of treatment in sarcoidosis.
@en
P2093
A Teirstein
B Thompson
G L Knatterud
M A Judson
R P Baughman
P304
P356
10.1093/QJMED/HCL038
P407
P577
2006-04-04T00:00:00Z